In both human immunodeficiency virus-infected humans and simian immunodeficiency virus (SIV)-infected macaques, genes encoded in the major histocompatibility complex (MHC) class I region are important determinants of disease progression. However, compared to the human human lymphocyte antigen complex, the macaque MHC region encodes many more class I genes. Macaques with the same immunodominant class I genes express additional Mhc genes with the potential to influence the disease course. We therefore assessed the association between of the Mhc class I haplotypes, rather than single gene variants, and survival time in SIV-infected rhesus macaques (Macaca mulatta). DNA sequence analysis and Mhc genotyping of 245 pedigreed monkeys identified 17 Mhc class I haplotypes that constitute 10 major genotypes. Among 81 vaccination-naive, SIV-infected macaques, 71 monkeys carried at least one Mhc class I haplotype encoding only MHC antigens that were incapable of inducing an effective anti-SIV cytotoxic T lymphocytes response. Study of these macaques enabled us to relate individual Mhc class I haplotypes to slow, medium and rapid disease progression. In a post hoc analysis, classification according to disease progression was found to explain at least 48% of the observed variation of survival time.
Introduction
Simian immunodeficiency virus (SIV)-infected rhesus macaques represent the primary animal model for human immunodeficiency virus (HIV) infection. 1 After infection with SIV, rhesus macaques develop symptoms of immunodeficiency that are remarkably similar to those of HIV-infected humans. The course of disease varies between infected monkeys as much as between HIV-infected humans. Even among animals infected with the same virus and dose, the time until onset of AIDS-defining symptoms varies between 7 weeks and 8 years post infection, indicating that host factors play a major role in determining disease progression.
The highly polymorphic Mhc genes represent the most important host factor influencing disease progression in HIV-infected patients. 1, 2 Major histocompatibility complex (MHC) class I antigens that present foreign peptides can activate cytotoxic T lymphocytes (CTL), which are crucial for containing viral replication. Several studies have shown (1) a temporal relationship between the decline of viral load and the emergence of CTL responses in both infected humans and infected monkeys, [3] [4] [5] [6] (2) an increase of viral load after the appearance of CTL-escape HIV/SIV mutants during chronic and acute infection [7] [8] [9] [10] [11] [12] [13] and (3) a dramatic rise of viral load after CD8 þ T-cell depletion. [14] [15] [16] Additional indirect evidence for a CTL effect upon viral replication came from genetic association studies showing that Mhc class I alleles are strongly associated with survival time in HIV-infected humans [17] [18] [19] [20] . The macaque Mhc region differs from the human lymphocyte antigen (HLA) complex by a larger number of Mhc class I genes. 21, 22 Even Mhc homozygous macaques may carry two or three expressed A genes, and even up to 10 expressed B genes. 23, 24 In contrast, only one A and one B gene exist in the human HLA class I region. This means that macaques sharing one Mhc allele triggering an immunodominant CTL response still express several other Mhc sequences. These other MHC molecules may also influence the disease course by inducing subdominant CTL responses, or by modulating killer immunoglobulin receptor (KIR)-MHC interactions. Several studies have shown that single MHC antigens such as Mamu-A*01 and -B*17 are significantly associated with prolonged survival in SIV-infected rhesus macaques. 13, [25] [26] [27] However, monkeys sharing one or two of these MHC antigens may still exhibit a variable course of disease. 27, 28 We therefore assessed the association between Mhc class I haplotypes, rather than single gene variants, and survival time in SIV-infected rhesus macaques. In order to obtain detailed information on the Mhc class I haplotypes present in the German Primate Center (GPC) breeding colony, the monkeys which were of Indian descent, we first performed a low-resolution Mhc typing on monkeys derived from three generations. For high-resolution Mhc typing, we developed typing techniques for additional Mhc class I loci and retyped a cohort of 245 monkeys, which comprised the SIVinfected monkeys as well as their ancestors and siblings. Almost all SIV-infected monkeys in our study cohort were found to carry at least one Mhc class I haplotype that was associated with rapid disease progression and was thus incapable of inducing a strong anti-SIV CTL response. Functionally, the SIV-infected monkeys were therefore 'quasi-hemizygous' which allowed us to investigate the contribution of the second haplotype to disease progression. Since the genealogies of the monkeys were known, we could also control for the potential familial influence of other host genes. We identified haplotypes of the Mhc class I region clearly associated with a rapid and slow disease course, and configurations that were characterized by a particularly large variation in survival time.
Results

Mhc class I haplotypes
Initially, monkeys of Indian descent from three generations housed at the GPC were typed for DQB1 and for 15 Mhc class I sequences or allele lineages, employing previously published techniques. 25, 29, 30 Segregation analysis revealed 19 DQB1-Mhc class I haplotypes. In order to obtain Mhc class I cDNA sequences of each haplotype, we subcloned reverse transcription (RT)-PCR products from 18 animals and sequenced approximately 1600 inserts. Transcribed Mhc class I sequences of the most frequent haplotypes were thus obtained from at least two unrelated animals. Sequence analysis revealed the presence of 45 distinct class I alleles. All except eight alleles had been published before. 24 Three of the novel alleles were highly similar to previously published sequences, namely Mamu-A1*2102, -B*4503 and -B*3003.
The alleles Mamu-B*7401 and -B*7402 differed from each other by a nonsynonymous mutation in the cytoplasmic region, and both diverge by either one or two nucleotides from an annotated rhesus macaque genomic DNA sequence (GenBank accession no. XR014617). Alternatively spliced transcripts of Mamu-B*74 were detected in seven individuals. They differ from Mafa-B*390101 (GenBank accession no. AY969136 31 ) by only one or two nucleotides. The splice variants are nonfunctional as they contain a frame shift mutation at the beginning of exon 3 due to a deletion of 74 bp. In two monkeys, both the spliced and the unspliced variant of either Mamu-B*7401 or -B*7402 were found. Mamu-B*74 therefore seems to have been conserved, but may not represent a classical B gene. Since genotyping revealed the presence of Mamu-B*74 in almost all animals, we did not investigate its association with disease progression or with specific Mhc class I haplotypes any further.
For additional genotyping purposes, 23 novel primer pairs were created which were sufficient to yield reliable results in our modestly diverse study population. A total of 245 animals, comprising the SIV-infected monkeys as well as their ancestors and siblings, were finally typed for 37 class I sequences or loci using the previously established and the novel primers. The genotyping results revealed that the initially assigned haplotypes were by and large correct. However, two haplotypes segregated into two and four related configurations. In total, 17 Mhc class I haplotypes encompassing the A and B regions were deduced and their frequencies were determined (Tables 1 and 2 ). They consisted of seven individual A and 14 B haplotypes. The number of expressed A genes varied between two and three. Notably, Mamu-A*1403 was not present in all haplotypes, as was reported for other rhesus macaques of Indian origin. 24 The number of expressed B genes varied between two and eight per haplotype. As many as 18 transcribed class I sequences were observed in some heterozygous monkeys. Since we may not have detected all transcribed genes, the true number may have been even larger.
In 200 investigated descendants, two potential recombination events were observed between the A and B region, but none within the B region. This means that we did not observe an enhanced recombination rate in the Mhc class I region.
Haplotypes significantly associated with rapid disease progression Four haplotypes (1.1-1.4; Table 2 ) were very similar in that they differed only by the presence or absence of one B gene. We combined them into a single group (group 1) because it was impossible to define the particular haplotypes, not only in monkeys with two different group 1 haplotypes, but also in other heterozygotes whose second haplotype carried Mamu-B*38 or -B*46. The 11 monkeys carrying only group 1 configurations were all euthanized within 31 weeks post infection (w.p.i.) with symptoms of AIDS and had a mean survival time of 20.5 w.p.i. (s.d. 6.5 w.p.i.; Table 3 ; Figure 1a ). Among them, the eight nonimmunized monkeys had an average survival time of 18.0 w.p.i. Thus, the group 1 configurations were significantly associated with rapid disease progression (P ¼ 0.0003).
For analytical reasons, we also combined all haplotypes containing members of Mamu-B*30, -B*07 loci/ lineages and Mamu-B*01 into group 2 (2.1, 2.2), regardless of which other genes were present, except Mamu-A*02. The six monkeys carrying both a group 1 and a group 2 haplotype also had to be euthanized with symptoms of AIDS soon after SIV infection, with a mean survival time of 18.0 w.p.i. (s.d. 5.1 w.p.i.; Figure 1b ; Table 3 ). Group 2 configurations were thus also associated with rapid disease progression (P ¼ 0.001).
One monkey with a group 1 and two monkeys with a group 2 haplotype on one chromosome, and type 19 on the other also displayed rapid disease progression with a mean survival of 19.0 w.p.i. (P ¼ 0.04; s.d. 2.0 w.p.i.; Figure 1c ; Table 3 ). Since no significant difference between the respective mean survival times was observed (logrank w 2 ¼ 1.617, two degrees of freedom (d.f.), P ¼ 0.446), groups 1, 2 and 19 haplotypes will henceforth be referred to as 'rapid progressor' haplotypes. Altogether, the monkeys carrying only rapid progressor haplotypes had a mean survival time (19.5 w.p.i., s.d. 5.7 w.p.i.) that was highly significantly shorter than that of the remaining genotypes (logrank w 2 ¼ 45.619, one d.f., Po0.0001).
The viral load was determined in five rapid progressors and was revealed to be higher than in monkeys with an intermediate or slow disease course (Figure 2) . Moreover, none of the three tested macaques displayed Elispot responses against Tat, Gag or Nef-peptide pools beyond 12 w.p.i. (Table 4 ). In none of the rapid progressors were anti-SIV antibodies detected (data not shown). We therefore concluded that none of the Mhc class I genes encoded by the rapid progressor haplotypes supported an effective, long-lasting anti-SIV immune response.
Altogether, 20 monkeys carried rapid progressor haplotypes on both chromosomes. Of the 61 remaining monkeys, 50 carried a rapid progressor genotype on one chromosome. These 'quasi-hemizygous' macaques enabled us to relate individual Mhc class I haplotypes to medium and slow disease progression. Two SIV-infected monkeys carried an unknown genotype since samples from the parents were unavailable. Nine monkeys carried one or two of the configurations described in Table 2 , but did not possess a rapid progressor genotype. Three haplotypes differed from the rapid progressor ones 1.2, 1.3 or 2.2, only by the presence of Mamu-A*02 ( Table 2 ), so that we were able to investigate the influence of this allele upon survival against a genetic background significantly associated with rapid disease progression ( Figure 1d ). Mamu-A*02 presents an epitope from each of Nef 32 and Gag in a dominant fashion, and several other epitopes subdominantly. 33 The estimated mean survival time of six monkeys from five independent breeding groups was 31.3 w.p.i., which represents an underestimate because the largest observation was censored. Nevertheless, the presence of Mamu-A*02 significantly prolonged survival in the respective animals (logrank w 2 ¼ 7.426, one d.f., P ¼ 0.006). Notably, the survival times and viral load of the Mamu-A*02 animals were found to vary considerably (Table 3 ; Figure 2 Figure 1j ). Two Mhc class I and class II identical sibling pairs from two families had Figure 1f ). Although this may still represent an underestimate due to censoring of the largest observation, we can assume that Mamu-B*17 was associated with an intermediate, rather than a slow, disease progression in our study cohort. Figure 1i ). Figure 1h ; Table 3 ), a lower viral load and longer-lasting Elispot responses compared to more rapidly progressing animals ( Figure 2 ; Table 4 ).
Haplotypes associated with slow disease progression
Mamu-A*01, which represents the best-studied rhesus Mhc allele, 34, 35 was encoded in haplotype 4. Six monkeys carrying this and group 1 haplotypes were derived from three breeding groups. Their mean survival time of 89.1 w.p.i. (s.d. 15.6 w.p.i.; Figure 1g ; Table 4 ) was significantly longer than that of the intermediate progressors (logrank w 2 ¼ 6.177, one d.f., P ¼ 0.013). Mamu-B*4701 is also present in the haplotype 4 encoding Mamu-A*01, which may explain to some extent the significant association of Mamu-A*01 with slow disease progression in our study cohort.
Influence of Mhc gene copy number variation on survival time
The number of transcribed Mhc class I genes in an individual may affect T-cell receptor repertoire and may thus indirectly determine the quality of CTL responses of the respective carrier. When the total number of Mhc class I and survival in SIV-infected macaques U Sauermann et al transcribed Mhc genes per genotype was related to individual survival time using a Cox proportional hazards model, the presence of more Mhc genes was found to correlate significantly with shorter survival (hazard ratio 1.19, P ¼ 0.002). This result indicates that mere copy number variation at the Mhc locus may already influence disease progression. The number of different Mhc genes expressed in an individual did not affect survival time significantly.
Contribution of Mhc class II genotypes to survival time
We have previously described Mhc class II genotypes associated with rapid disease progression in rhesus macaques of different origin. 36 Reinspection of these data revealed that, in the GPC cohort, Mhc class II genotype Mamu-DQB1*0601-DRB1*0309-DRB*W201 was linked to Mhc group 1 haplotypes and to those containing Mamu-A*02 (1.3-A*02 and 2-A*02; Table 2 ), all of which are associated with a more rapid disease progression. Because of this strong linkage we were unable to quantify the potential contribution of this Mhc class II genotype to disease progression. However, homozygous monkeys express only one DRB gene, which may be disadvantageous. Mhc class I group 1 and group 2 configurations were also linked to Mhc class II haplotypes expressing two DRB genes, namely Mamu-DQB1*1801-DRB1*0303-DRB1*1007 and Mamu-DQB1*1811-DRB1*0406-DRB5*0301.
37
One of them (Mamu-DQB1*1801-DRB1*0303-DRB1*1007) was also linked to class I configurations associated with slow disease progression, including configuration 4. This finding indicates that Mhc class I genotypes have a much more marked influence upon disease progression than class II genotypes, thereby corroborating previous reports on HIV-infected humans 20 and SIV-infected macaques. 38 Mhc region configurations explain at least 48% of the variation in disease progression In order to somehow quantify the overall influence of the Mhc genotype on disease progression in our study cohort, we performed a post hoc unbalanced one-way analysis of variance (ANOVA) of the 60 observed event times (that is, euthanizations with AIDS). Classification of a genotype as either 'slow', 'intermediate', 'rapid progressor' or 'unknown' was found to be a highly significant explanatory variable for onset of AIDSdefining symptoms (F ¼ 53.2, Po0.0001). The coefficient of determination of the fitted model was R 2 ¼ 0.478, which implies that the classified genotype explained 47.8% of the variation in survival time.
Discussion
The present study reports upon the relationship between survival time in SIV-infected monkeys and 17 Mhc class I region haplotypes, which were deduced by cDNA sequencing and extensive typing of three generations of rhesus macaques housed at the GPC. Our data validate and extend previous descriptions of the rhesus macaque Mhc class I region. Although the internal variability of a single locus generally appears to be low, the Mhc class I A and B regions display considerable variation in terms of the number and combination of transcribed Mhc class I genes. [21] [22] [23] [24] We detected two or three transcribed A genes per Mhc region and three novel A haplotypes in addition to the four that had been published before. 24 Only one configuration displayed allelic polymorphism (Mamu-A1*2102-A2*2401-A3*1303) when compared to a published haplotype. 24 In contrast to one report, 24 we failed to detect Mamu-A4*14 alleles in eight of the 17 haplotypes analyzed here. For genotyping Mamu-A4*14, we used primers specific for Mamu-A4*1403 as well as published primers amplifying all Mamu-A4*14 alleles. 24 In the B region, we found two to seven transcribed genes per haplotype. Nine B region haplotypes are novel; five had been published before. 24 Furthermore, we identified one Mhc class I gene, Mamu-B*74, which is conserved between cynomolgus and rhesus macaques and which seems to be subject to alternative splicing. The variability of the Mhc region is exemplified by the four 'group 1' haplotypes (Table 2) which differ from each other only by the presence or absence of one of the seven B genes examined here. In addition, some genes are present on several B region haplotypes. Although these results indicate a great plasticity of the rhesus Mhc, we Mhc class I and survival in SIV-infected macaques U Sauermann et al have not obtained any evidence for an enhanced recombination rate in that region. This is in agreement with a similar lack of evidence for an enhanced recombination rate in the human MHC region. 39 The most important aim of our study was to assess the impact of Mhc class I-genotypes on disease progression in SIV-infected rhesus macaques. Therefore we studied the influence of Mhc class I haplotypes upon disease progression in SIV infection, rather than single gene alleles. This was feasible because of the relatively low genetic variation of both the GPC rhesus monkey cohort and the infecting virus.
Initially, we identified three groups of Mhc class I haplotypes associated with rapid disease progression ( Table 2 ). Even immunized macaques carrying these haplotypes died within 31 w.p.i. As a further indicator for fast disease course (1) Elispot data revealed shortlived responses in the rapid progressors and (2) viral load was highest in these animals. Additional evidence suggests that some MHC antigens are unable to induce an efficient anti-SIV immune response. In the case of Mamu-B*01, this concurs with previous reports. 25, 40 Other sequences have been reported to be expressed only at low levels, such as Mamu-B*57 and -A*1303.
24 Taken together, we have identified for the first time Mhc class I haplotypes associated with rapid disease progression. Furthermore, the respective haplotypes can be considered as recessive in relation to 'protective' Mhc genes/ haplotypes which impede fast disease progression.
By investigating groups of monkeys that carried a haplotype associated with rapid disease progression on one chromosome, we identified two haplotypes significantly associated with slow disease progression ( Table 2) . One of the haplotypes carried only genes that are present on the rapid progressor genotypes, except Mamu-B*4701. Mamu-B*4701 therefore appears to be a candidate gene to induce strong anti-SIV CTL responses. In addition, the presence of Mamu-B*4701 on the haplotype 4, which also carries Mamu-A*01, may further explain why Mamu-A*01 is most strongly associated with slow disease progression in our monkey colony.
We also identified region configurations potentially associated with an intermediate type of disease progression. The respective survival times differed significantly from those of the rapid and the slow progressors. Interestingly, the s.d. values of the survival time varied greatly in this intermediate progressor group, ranging from 29 to 65% of the mean. In contrast, the s.d. did not exceed 32% of the mean for the region configurations associated significantly with slow or rapid disease progression.
Genotypes displaying a lower variation of the survival time were configuration 30 and the configurations carrying Mamu-B*17. Configuration 30 uniquely carried Mamu-B*65 and -B*6901 (GenBank accession no. AY844601), which may potentially induce a consistent CTL response. Mamu-B*6901 corresponds to the allele formerly termed NB2, which had been found to be associated with slow disease progression in SIV-infected monkeys of diverse origin. 25 Thus, in all animals carrying rapid progressor genotypes, slow progressor genotypes, Mamu-B*17, or configuration 30, the Mhc genotype was found to be broadly predictive of the principal disease course. Our study suggests that about 48% of the overall variation in disease progression in SIV-infected macaques can be explained by specific Mhc genotypes. Monkeys carrying these genotypes are therefore useful to examine the efficacy of any treatment against AIDS. The effects can be investigated in animals with differing immunogenetic background predicting different types of disease progression.
Several Mhc-sequences (Mamu-A*02, -B*26, -B*27, -B*43, -B*68, -B*6903 or -B*7501) were associated with an intermediate albeit more variable survival time, characterized by an s.d. value above 40% of the mean. Possibly, these molecules can also induce anti-SIV CTL responses but they may be less potent than, for instance, those of Mamu-A*01 carriers, as has been shown for Mamu-A*02. 41 The kinetics of the CTL response and stochastic events related to viral mutation rate and T-cell receptor repertoire may have a more profound impact upon survival in these animals than in those that induce a more consistent CTL response. 42 Additionally, copy number variation of Mhc genes appears to influence disease progression. According to our results, the presence of more transcribed Mhc genes correlated with shorter survival time. These results are surprising as probably per haplotype no more than two or three B genes are highly transcribed. 24 The other Mhc genes are expressed at low to very low levels. It is unlikely that they induce a strong CTL response. However, processed peptides of these proteins may be bound by other MHC molecules and play a role in thymic education. Interestingly, three of the genotypes displaying a large variation of survival time encoded many transcribed Mhc genes. However, these findings merit further investigation.
Another explanation may be that the large variation in survival time is a specific attribute of some of the MHC antigens present on these genotypes. We may hypothesize that disease progression in these animals is influenced by a specific interaction between particular MHC antigens and polymorphic MHC receptors located outside of the Mhc region. We may speculate that the KIR, which are expressed on natural killer (NK) cells are likely candidates for the type of MHC receptors referred to above. Several reports have demonstrated that the presence of specific KIR-MHC pairs influence HIVinduced disease progression, [43] [44] [45] the onset of opportunistic infections in HIV-infected patients 46 and the probability of becoming HIV infected. 47 Results from ex vivo viral replication assays in SIV-infected rhesus macaques showed that NK cells can suppress viral replication substantially but to a variable extent. 48 As yet, no study of the interaction between particular macaque KIR and MHC antigens has been published. The results presented here may provide first clues as to the macaque MHC antigens interacting with KIRs. The macaque model of AIDS may become highly valuable for examining the interplay between innate and adaptive immune responses and, most notably, for determining their impact upon vaccine efficacy.
Materials and methods
Animals, genealogies and viruses
All rhesus monkeys analyzed in the present study were of Indian descent and were bred at the GPC, Gö ttingen. The 81 SIV-infected macaques represented descendants of animals originally derived from the Caribbean Primate Research Center colony on Cayo Santiago, Puerto Rico. Parenthood of the monkeys was assessed as described. 49 All SIV-infected animals were housed at the GPC according to the German animal protection Act which complies with the European Union guidelines on the use of nonhuman primates for biomedical research. Experimental data from most of the animals have been published before. 25, 36, 50 All monkeys were naive with respect to immunization against SIV or any other antiviral treatment, except for the six immunized monkeys displaying the rapid progressor phenotype. A total of 30 animals were infected with SIV mac 251 grown on monkey peripheral blood mononuclear cells (PBMC). Altogether 21 animals were infected with SIV mac 251/ 32 H grown on the human T-cell line C8166. A total of 9 animals were infected with the ex vivo isolate SIV mac 251/ 32H/spl, and 21 monkeys were infected with SIV mac 239 grown on rhesus monkey PBMCs. The infecting virus did not significantly affect the survival time when the analysis was controlled for the presence or absence of a rapid progressor genotype (data not shown). None of the SIV-infected monkeys of this study was an elite controller.
Diagnosis of AIDS-like disease
The 48 animals that were euthanized before 47 w.p.i. had symptoms of AIDS-like disease, whereas only 12 of the 33 animals euthanized at a later time point had AIDSrelated symptoms. Thus, the survival time of slow progressors may be underestimated and is indicated in the respective tables. Those monkeys which were euthanized with signs of AIDS-related symptoms suffered from anorexia, incurable diarrhoea, Pneumocystis carinii pneumonia infection or from neurological dysfunction evident by ataxia as judged from clinical as well as detailed necropsy findings, which were available for each monkey. 36 CD4 þ T-cell counts turned out to be an inadequate marker for the diagnosis of AIDS since many rapid progressors still had increasing CD4 þ counts by the time of euthanasia. 36, 51, 52 Viral RNA copy number could not be used as a proxy for AIDS as many monkeys were infected at a time when RNA copy number was not routinely analyzed. However, for most monkeys cellassociated viral load data were available. 53 PCR amplification, cloning and sequence analysis of Mhc class I sequences From 18 selected monkeys, RNA was isolated from Herpes papio virus-transformed B-cell lines or PHAstimulated PBMCs using the Qiagen RNeasy Midi kit (Qiagen, Hilden, Germany). A toal of 10 mg RNA was used to produce cDNA employing a double-stranded cDNA synthesis kit (Invitrogen, Carlsbad, CA, USA). The cDNA was purified by phenol-chloroform extraction. A toal of 1 ml of a tenfold dilution was used to amplify Mhc class I gene sequences. Mamu-A sequences were amplified using primers Mamu-Afor (5 0 -GATGGCGCCCCGAA CCCTCCTCCTGG) and Mamu-Arev (5 0 -GGCCTCG CAGTCCCACACAA), Mamu-B-sequences were amplified with primers Mamu-Bfor (5 0 -GATGGCGCCCC GAACCCTCCTCCTG) and Mamu-Brev (5 0 -GCTTTGCA GAAAGAGATGCCAGAG), each at a concentration of 0.4 mM. For each animal, Mamu-A and -B sequences were amplified twice using different heat-stable DNA polymerases (expand high-fidelity PCR System, Roche Diagnostics, Switzerland; high-fidelity PCR enzyme mix, Fermentas GmbH, St Leon, Germany). PCR reactions were performed in an initial denaturing step at 94 1C for 3 min, followed by 25 cycles of denaturation at 95 1C for 30 s, an annealing step at 60 1C and an elongation step at 72 1C for 72 s. The elongation step was prolonged by 4 s per cycle with a final elongation for 15 min. After agarose gel purification of the PCR products, ligation and cloning were performed with the TOPO-TA cloning kit for sequencing (Invitrogen) according to the manufacturer's instructions. Plasmid DNA was prepared with the Qiaprep Spin Miniprep procedure (Qiagen). Per PCR reaction, 10-12 individual clones containing A sequences or 20-30 clones containing B sequences were sequenced using the Dye terminator chemistry (Applied Biosystems) on a 3730 Â L DNA Analyzer (Applied Biosystems). DNA sequence alignment was performed using the BioEdit programme (www.mbio.ncsu.edu/BioEdit/ bioedit.html). Identical novel DNA sequences obtained in at least three independent PCR reactions were registered at the Biomedical Primate Research Center, the Netherlands 54 and submitted to GenBank (accession no. EF219477-EF219486, EU157186).
Mhc genotyping
The rhesus macaques of the GPC were initially typed for DQB1 and for Mhc class I genes using published techniques. 25, 29, 55 For the novel class I alleles, a total of 23 primer pairs were created (Table 1) . Allele-specific PCR products ranged in size between 408 and B1300 bp. DRB-specific primers (MDRB-5 0 and 3 0 -MDR) or actin gene primers served as internal controls. 55, 56 HPLCpurified primers were obtained from VBC-GENOMICS Bioscience Research (Vienna, Austria). Reaction mixtures of 25 ml contained 100-150 ng DNA, PCR buffer, Qsolution, 200 mM dNTP, 750-800 mM allele-specific forward and reverse primer, 80-120 nM of the internal control primers and 1.25 unit Taq polymerase (Qiagen). The samples were denatured initially at 95 1C for 3 min, followed by 38 cycles at 95 1C for 30 s, 58-64 1C for 40 s, 72 1C for 40 s and a final elongation step at 72 1C for 2 min. Allele-specific products were identified by electrophoresis of amplicons in 1% agarose gels containing ethidium bromide.
Elispot assay
Elispot assays were performed as described. 50 Briefly, purified PBMCs were resuspended in Elispot medium and seeded in triplicate in wells coated with anti-human IFN-g monoclonal antibody. For antigenic stimulation, SIV Gag (15-mer, EVA7066, NIBSC) and Nef peptides (20-mer, EVA777, NIBSC), peptide pools or SEB were included in the medium. Cells were removed after incubation for 20 h. IFN-g was determined by biotinylated anti-human IFN-g detector antibody (Mabtech, Augustendalsvägen, Sweden) followed by the addition of strepavidin-alkaline phosphatase conjugate, and a final incubation with NBT/BCIP solution. Spots were counted using a BIOSYS2000 Elispot reader. All counts were normalized to a total of 10 6 cells. Samples yielding more than 100 s.f.c. per 10 6 PBMC above background, and twice that of the medium control, were scored as positive.
RNA copy numbers Viral RNA was isolated from frozen plasma samples following the MagAttract Virus Mini M48 protocol (Qiagen). RNA copy number in infected monkeys was determined by quantitative real-time PCR as described 57 using TaqMan-based real-time PCR on an ABI-Prism 7500 sequence detection system (Applied Biosystems). Levels of amplified viral RNA were expressed as SIV-RNA copies per ml plasma.
Statistical analysis
Survival analysis was performed using the LIFETEST procedure of the SAS software package (SAS version 9.1, SAS Inc., Cary, NC, USA). In order to reduce bias in the estimation of the mean and standard deviation of genotype-specific survival times, the largest observation per genotype was consistently treated as an event time. It should be noted, however, that the results may still be systematically biased downward in cases where the largest observation was right censored. Differences between genotype-specific survival curves were assessed for statistical significance using a logrank test with the appropriate d.f. Unbalanced ANOVA of event times was performed using SAS procedure REG. The influence of the number of transcribed Mhc genes upon aids-free survival was assessed for statistical significance using a Cox proportional hazards model, as implemented in SAS procedure PHREG.
